Continuation with apixaban treatment is associated with lower risk for hospitalization and medical costs among elderly patients

导出原文传递

翻译打印收藏纠错

作者： Dhamane, Amol D. ^[1] ; Baker, Christine L. ^[2] ; Rajpura, Jigar ^[3] ; Mardekian, Jack ; Dina, Oluwaseyi ; Russ, Cristina ; Rosenblatt, Lisa ; Lingohr-Smith, Melissa ; Lin, Jay

作者单位： Novosys Hlth, Green Brook, NJ USA ^[1] Bristol Myers Squibb, Lawrenceville, NJ 08648 USA ^[2] Pfizer Inc, New York, NY USA ^[3]

关键词 Apixaban continue treatment hospitalization major bleeding nonvalvular atrial fibrillation oral anticoagulant stroke switch treatment systemic embolism

发布时间 2020-02-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Current medical research and opinion

2019年35卷10期

1769-1776页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Continuation with apixaban treatment is associated with lower risk for hospitalization and medical costs among elderly patients

Current medical research and opinion

相似文献

Current medical research and opinion

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Continuation with apixaban treatment is associated with lower risk for hospitalization and medical costs among elderly patients

Current medical research and opinion

相似文献

Current medical research and opinion

相关期刊

检索历史清除